31 maj: Skattereform: Ny kapitalpension er generationsrøveri til 150 mia...
03 jun: SimCorp på vej mod solid opjustering
31-05-2012 15:04:00

US HOT STOCK FUTURES: HOT STOCKS TO WATCH

Relateret indhold

Among the companies with shares expected to actively trade in Thursday's session are Lions Gate Entertainment Corp. (LGF), TiVo Inc. (TIVO) and Talbots Inc. (TLB).

Lions Gate Entertainment swung to a fiscal fourth-quarter loss as the movie and television studio saw higher marketing and acquisition expenses overshadow soaring revenue from its two blockbuster young-adult series. Shares slid 3.5% to $12.40 premarket amid the surprise loss.

TiVo swung to a fiscal first-quarter loss as litigation and marketing expenses rose, though the company reported an increase in subscribers. Shares slid 5.7% to $8.45 premarket as the company also issued a downbeat second-quarter outlook.

Talbots agreed to be acquired by Sycamore Partners in a deal valued at about $193.3 million, far less than the struggling retailer stood to receive in a potential deal that fell apart last week. The struggling retailer's shareholders will receive $2.75 a share, down from the former offer of $3.05 a share. Shares more than doubled premarket to $2.58 after tanking in the wake of the failed bid.

Leap Wireless International Inc.'s (LEAP) Cricket prepaid phone service will start selling Apple Inc.'s (AAPL) iPhone next month, making it the first prepaid carrier to offer the device in the U.S. Shares jumped 5.8% to $5.77 in premarket trade following the disclosure.

Ciena Corp.'s (CIEN) fiscal second-quarter loss narrowed amid fewer acquisition and integration-related charges and as the network gear maker also posted stronger-than-expected revenue growth. Shares were up 6.7% at $12.68 in premarket trading as Ciena reported a surprise adjusted profit. Peer JDS Uniphase Corp. (JDSU) also traded up, gaining 0.7% to $10.07 premarket.

Movado Group Inc.'s (MOV) fiscal first-quarter profit surged as the luxury watchmaker had robust sales growth of its accessible luxury and licensed-brand categories. Shares climbed 2.6% to $29.21 premarket.

Joy Global Inc.'s (JOY) fiscal second-quarter earnings rose 32% as the mining equipment maker increased shipments in its core underground and surface mining businesses, helped by recent acquisitions. But while its results topped consensus, the company isn't terribly optimistic near-term, listing a litany of concerns ranging from slowing growth in China to the euro-zone woes to a lack of economic catalysts in the U.S. Shares slipped 1.9% to $57.76 premarket.

F5 Networks Inc. (FFIV) said its head of worldwide sales, Executive Vice President Mark Anderson, resigned after about eight years with the network-equipment provider company. He was replaced by Dave Feringa, senior vice president for Americas sales. Shares dropped 3.7% premarket to $103.60 amid the departure.

National Oilwell Varco Inc. (NOV) agreed to acquire CE Franklin Ltd. (CFK, CFT.T) for about C$231 million, giving the manufacturer of energy-production equipment a supplier of similar products. National Oilwell plans to pay C$12.75 per share for CE Franklin, a 36% premium over its Wednesday closing price on the Toronto Stock Exchange. CE Franklin's U.S.-traded shares jumped 35% to $12.25 premarket.

Chelsea Therapeutics International Ltd. (CHTP) said a recent clinical study of its investigational rheumatoid arthritis treatment CH-4051 missed a primary endpoint and the small drug maker had no further plans to develop the medication. Shares fell 18% to $1.60 in premarket trading.

BioMarin Pharmaceutical Inc. (BMRN) said it will offer 6.5 million shares and retained broad discretion on the use of the funds. Shares were down 4% at $36.76 premarket.

Coldwater Creek Inc.'s (CWTR) fiscal first-quarter loss narrowed as the women's apparel retailer reported lower overhead costs and improved margins, though revenue fell more than expected. Shares rose 6.6% premarket to 90 cents.

Watchlist:

Biopharmaceutical firm Alkermes PLC (ALKS) said it won't advance its study of its opioid-induced constipation treatment, ALKS 37, after the drug failed to meet the company's goals in a recent trial.

AptarGroup Inc. (ATR) has agreed to acquire the Stelmi Group, a maker of elastomer primary-packaging components for injectable drug delivery, for approximately EUR165 million ($207 million) in a deal that expands the dispenser maker's offerings for the pharmaceutical industry.

AT&T Inc. (T) reached a tentative agreement for a one-year contract extension for nearly 7,000 core wireline workers, an agreement that comes before the contract expires on June 23.

Endologix Inc. (ELGX) said it planned to offer 2.7 million shares, as the company looks to use the proceeds for general-corporate needs, which may include research and development and capital expenditures.

MSCI Inc. (MSCI) said Chief Financial Officer David M. Obstler will resign to pursue other interests, and Robert Qutub was appointed to replace him.

Noble Energy Inc. (NBL) agreed to sell its stake in certain properties in the U.K.'s North Sea to Maersk Oil North Sea Ltd. for about $127 million, as the oil-and-gas explorer continues to divest its noncore properties.

NV Energy Inc. (NVE) on Wednesday said its Chief Financial Officer Dilek Samil would become chief operating officer, and named Caesars Entertainment Corp.'s (CZR) financial chief Jonathan Halkyard as its new CFO.

Tengion Inc. (TNGN) said its board approved a 1-for-10 reverse stock split in an effort to raise the clinical-stage regenerative medicine company's per-share trading price above $1 to comply with Nasdaq listing requirements.

Zumiez Inc. (ZUMZ) posted a 13.7% jump in May same-store sales while analysts expected a 6.6% rise. The company has been on a tear, delivering strong numbers as teenage consumers respond to its surfing- and snowboarding-related apparel.

-Edited By Corrie Driebusch and Nathalie Tadena, Dow Jones Newswires; 212-416-2143; corrie.driebusch@dowjones.com

(END) Dow Jones Newswires

May 31, 2012 09:04 ET (13:04 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
17 feb
AAPL
Prøv lige at læse din egen trådstart igen: “Kina har netop meddelt at apple ikke må producere i land..
8
17 feb
AAPL
Helt enig, men taastrup har en dårlig vane, med at slynge om sig med udokumenterbare påstande.
4
18 feb
AAPL
Taastrup  -  alle ved sgu da hvad en handelskrig er.   Og alle ved du er fuld af løgn når du siger d..
3
17 feb
AAPL
Taastrup, Jeg hæfter mig ved, at du nu i dette indlæg formulerer dig i fremtidsform. Kina har altså ..
3
17 feb
AAPL
Taastrup, Det må du simpelthen kunne gøre bedre. Du må i sagens natur have oplysningen et sted fra. ..
3
18 feb
AAPL
http://onx.dk/nyheder/iphone-x-er-verdens-mest-solgte-smartphone-i-oejeblikket/
2
18 feb
AAPL
Under World Economic Forum i januar roste milliardæren George Soros den danske EU-konkurrencekommiss..
2
17 feb
AAPL
så må vi have margrethe vestager ind over...det er da for galt? stavnsbinding  af ytringsfriheden må..
2
17 feb
AAPL
Taasturp - nu ved jeg ikke hvad kun jeg ved (som du skriver) - Men jeg VED at der ikke står noget om..
2
17 feb
AAPL
Fake news!
2

Fondsbørsmeddelelser

Aktier/tendens: William Demant kan tage fokus i grøn åbning

23-02-2018 08:27:52
Der er udsigt til stigninger fredag morgen, når aktiemarkedet herhjemme åbner. Fra åbningen kan William Demant igen tage fokus, efter at selskabet har fået hævet kursmålet af en stribe finanshuse ovenpå torsdagens positive regnskab. I USA lukkede S&P 500 torsdagens handel med et plus på 0,2 pct., mens også Dow Jones lukkede med en gevinst på 0,7 pct. Til gengæld faldt Nasdaq med 0,1 pct. Futures f..

Aktier/middag: Genmab buldrer frem med WDH og ISS som følgesvende

22-02-2018 11:40:57
Biotekselskabet Genmab ligger helt i top i det danske eliteindeks torsdag middag efter at have præsenteret regnskab onsdag aften. Også ISS og William Demant, der begge kom med regnskab for fjerde kvartal torsdag morgen, er med i toppen.Men det er onsdagens regnskab fra Genmab, der trækker den helt store opmærksomhed, efter at biotekselskabet gjorde markedets bekymringer over en mulig skuffende pro..

ISS: Salget vokser mens bundlinjen skrumper

22-02-2018 08:39:00
ISS kan se bundlinjen falde tilbage i 2017 sammenlignet med i 2016, selvom selskabet er vokset på salget.Omsætningen i selskabet voksede til 79.912 mio. kr. i 2017, mens omsætningen udgjorde 78.658 mio. kr. i 2016.Omvendt steg nettoresultatet i 2017 til 2007 mio. kr. mod 2220 mio. kr. året før.Af regnskabet fremgår det, at årsagen til at bundlinjen ikke vokser med toplinjen, blandt andet er ekster..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Genmab og Novo udvider samarbejde - citat
2
Nilfisk-konkurrent afviser fusion - aktien falder tungt - NY
3
Novo/Redburn: Hæver anbefalingen til "køb" fra "neutral"
4
Aktier/tendens: William Demant kan tage fokus i grøn åbning
5
Formuepleje: Fed hæver renten fire gange i år - ECB gør slet ikke

Relaterede aktiekurser

AptarGroup Inc 90,41 0,0% Aktiekurs uændret
AT&T Inc 36,72 0,0% Aktiekurs uændret
Noble Energy Inc 30,66 0,0% Aktiekurs uændret
Wells Fargo & Company 59,17 0,0% Aktiekurs uændret
Apple Inc 175,50 0,0% Aktiekurs uændret
BioMarin Pharmaceutical .. 83,05 0,0% Aktiekurs uændret
TiVo Corporation 13,63 0,0% Aktiekurs uændret
Movado Group Inc 31,85 0,0% Aktiekurs uændret
Armadale Capital PLC ORD.. 2,03 0,0% Aktiekurs uændret
National Oilwell Varco I.. 36,07 0,0% Aktiekurs uændret
Zumiez Inc 19,95 0,0% Aktiekurs uændret
Msci Inc 144,82 0,0% Aktiekurs uændret
Caesars Entertainment Co.. 13,15 0,0% Aktiekurs uændret
Alkermes PLC - Ordinary .. 58,60 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
24. februar 2018 06:53:57
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseBuild_20180222.1 - EUROWEB3 - 2018-02-24 06:53:57 - 2018-02-24 06:53:57 - 1 - Website: OKAY